Announcements Trials
Browse Landscape

Status

Completed 15Unknown 8Terminated 3Recruiting 3Not yet recruiting 3Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 119Neoplasms 100Lung Neoplasms 66Colorectal Neoplasms 62Carcinoma, Hepatocellular 56Carcinoma, Non-Small-Cell Lung 53Prostatic Neoplasms 48Uterine Cervical Neoplasms 36Pancreatic Neoplasms 36Stomach Neoplasms 29Ovarian Neoplasms 28Disease 28Rectal Neoplasms 27Multiple Myeloma 25Leukemia, Myeloid, Acute 21Head and Neck Neoplasms 21Esophageal Neoplasms 21Endometrial Neoplasms 21Recurrence 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Colonic Neoplasms 18Neoplasm Metastasis 17Glioma 17Glioblastoma 17Melanoma 15Lymphoma 15Cholangiocarcinoma 14Urinary Bladder Neoplasms 13Neoplasm, Residual 13Liver Neoplasms 12

Interventions

tislelizumab 1Immune Checkpoint Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Observational × Hypersensitivity × Clear all
NCT07572162 2026-05-07

Post-market Safety Study of LUMISIGHT

Lumicell, Inc.

Not yet recruiting
1,500 enrolled
Breast

Anaphylaxis, Breast Neoplasms, Drug Hypersensitivity, Hypersensitivity

NCT07209774 2025-10-07

Healthspan Connect Programme of Research

King's College London

Not yet recruiting
100,000 enrolled

Psychological Well-Being, Hypersensitivity, Neoplasms

NCT06448169 2024-06-07

Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer

Shandong University

Not yet recruiting
200 enrolled
Breast

Hypersensitivity, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡